Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma.

Weihua Zhang Lei ChenYanyan CaoBo SunYanqiao RenTao SunChuansheng Zheng

Published in: Cancer management and research (2021)

Patients with unresectable HCC treated with D-TACE-A might not show increased survival compared with patients treated with C-TACE-A. Advanced HCC patients without cirrhosis may receive greater survival benefits from C-TACE-A than D-TACE-A.

Keyphrases

liver metastases
radiofrequency ablation
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
locally advanced
peritoneal dialysis
squamous cell carcinoma
combination therapy